Has Geoffrey Emerson, MD received payments from drug or device companies?

Yes. Drug and device makers reported $500 in general payments to Geoffrey Emerson, MD across 1 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Geoffrey Emerson, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Geoffrey Emerson, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Geoffrey Emerson, MD

Retina Specialist · Minneapolis, MNNPI 1801848171

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $500 of the $500 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Bausch & Lomb, A Division Of Bausch Health US, LLC. That places this record below the midpoint for retina specialist clinicians in MN, where the typical reported total is $500.

$500in general payments, 2019–2025

Across 1 payment — averaging $500.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Bausch & Lomb, A Division Of Bausch Health US, LLC$500

What the payments were for

Speaking & faculty fees$500100%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Bausch & Lomb, A Division Of Bausch Health US, LLC	1	$500

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$500 in reported general payments places this provider in the 50th percentile of 20 retina specialist providers in Minnesota.

See all retina specialist providers in Minnesota →

Medicare billing

Part B allowed, 2024

$4,408,826

Medicare patients

1,132

Services billed

18,413

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Prednisolone Acetate	330	$18,515
Ketorolac Tromethamine	118	$2,991
CombiganBrimonidine Tartrate/Timolol	11	$2,657
Latanoprost	138	$2,556
Fluorometholone	16	$2,005
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat	92	$1,562
Brimonidine Tartrate	67	$1,361
Timolol Maleate	51	$816
Atropine Sulfate	14	$606
Dorzolamide Hcl	20	$367
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha	14	$271
ErythromycinErythromycin Base	12	$161

Paid to pharmacies, not to this prescriber.

Other retina specialist in Minneapolis

Abdhish BhavsarMinneapolis$21K
Hossein NazariMinneapolis$377
Jacob JonesMinneapolis$164
Yevgeniy SychevMinneapolis$0
Malav JoshiRochester$293K
Zeeshan HaqEdina$12K
David WilliamsBaxter$9K
Michael MaywoodEdina$5K
Guneet SodhiEdina$3K
Sahal SalehEdina$3K

See the full list for Minnesota →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →